Publikationen in Zusammenarbeit mit Forschern von Hospital de Cruces (72)

2024

  1. De-imFAR phase II project: a study protocol for a cluster randomised implementation trial to evaluate the effectiveness of de-implementation strategies to reduce low-value statin prescribing in the primary prevention of cardiovascular disease

    BMJ Open, Vol. 14, Núm. 4

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Altered Red Blood Cell Fatty Acid and Serum Adipokine Profiles in Subjects with Obesity

    Biomedicines, Vol. 11, Núm. 12

  3. Autoimmune Diabetes From Childhood to Adulthood: The Role of Pancreatic Autoantibodies and HLA-DRB1 Genotype

    The Journal of clinical endocrinology and metabolism, Vol. 108, Núm. 11, pp. e1341-e1346

  4. Change in physical activity related to admission for exacerbation in COPD patients

    Respiratory Medicine, Vol. 212

  5. Correction to: Predictors of short‑term COPD readmission (Internal and Emergency Medicine, (2022), 17, 5, (1481-1490), 10.1007/s11739-022-02948-4)

    Internal and Emergency Medicine

  6. Isolation and Differentiation of Neurons and Glial Cells from Olfactory Epithelium in Living Subjects

    Molecular Neurobiology, Vol. 60, Núm. 8, pp. 4472-4487

  7. Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma

    Journal of Hepatology, Vol. 79, Núm. 1, pp. 93-108

  8. Physical activity and sedentary behaviour in patients admitted with COPD: Associated factors

    Respiratory Medicine and Research, Vol. 84

2022

  1. Application of a Platform for Gluten-Free Diet Evaluation and Dietary Advice: From Theory to Practice

    Sensors, Vol. 22, Núm. 3

  2. Characterization of molecular biomarkers in cerebrospinal fluid and serum of E46K-SNCA mutation carriers

    Parkinsonism and Related Disorders, Vol. 96, pp. 29-35

  3. Key Factors in Effective Patient-Tailored Dosing of Fluoroquinolones in Urological Infections: Interindividual Pharmacokinetic and Pharmacodynamic Variability

    Antibiotics, Vol. 11, Núm. 5

  4. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  5. Optimization of levetiracetam dosing regimen in critically ill patients with augmented renal clearance: a Monte Carlo simulation study

    Journal of Intensive Care, Vol. 10, Núm. 1

  6. Predictors of short-term COPD readmission

    Internal and Emergency Medicine, Vol. 17, Núm. 5, pp. 1481-1490

  7. Unraveling the Signaling Secretome of Platelet-Rich Plasma: Towards a Better Understanding of Its Therapeutic Potential in Knee Osteoarthritis

    Journal of Clinical Medicine, Vol. 11, Núm. 3

2021

  1. Biomarkers for the diagnosis of invasive candidiasis in immunocompetent and immunocompromised patients

    Diagnostic Microbiology and Infectious Disease, Vol. 101, Núm. 3

  2. Clinical implications of (Pro)renin receptor (prr) expression in renal tumours

    Diagnostics, Vol. 11, Núm. 2

  3. Population pharmacokinetics of levetiracetam and dosing evaluation in critically ill patients with normal or augmented renal function

    Pharmaceutics, Vol. 13, Núm. 10

  4. Soluble pd-l1 is an independent prognostic factor in clear cell renal cell carcinoma

    Cancers, Vol. 13, Núm. 4, pp. 1-17